{
  "paper_metadata": {
    "pmid": "30478886",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variant Val30Met, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.30G>A",
      "protein_notation": "p.Val10Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "73-year-old Japanese male",
        "phenotype": "TTR amyloid cardiomyopathy with ocular amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": 73,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "TTR amyloid cardiomyopathy, vitreous opacities, chronic glaucoma",
          "evidence_sentence": "A 73\u2010year\u2010old Japanese man was transferred to our hospital with dyspnoea... Genetic analysis revealed Val30Met mutation (GTG\u00a0\u2192\u00a0ATG), indicating a diagnosis of hereditary TTR amyloidosis."
        }
      ],
      "functional_data": {
        "summary": "The Val30Met mutation is associated with TTR amyloidosis, leading to cardiac and ocular manifestations.",
        "assays": []
      },
      "segregation_data": "Not mentioned",
      "population_frequency": "Not mentioned",
      "evidence_level": "Strong evidence based on clinical presentation and genetic analysis.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The paper discusses the efficacy of tafamidis treatment in this patient.",
      "key_quotes": [
        "Our case suggests that tafamidis may be effective in suppressing cardiac progression in TTR amyloid cardiomyopathy with Val30Met mutation."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "The extraction was straightforward as the paper provided clear information on the TTR variant."
  }
}